The Role of Polymorphic Short Tandem (CA)n Repeat Loci Segregation Analysis in the Detection of Duchenne Muscular Dystrophy Carriers and Prenatal Diagnosis

Emery AEH. Duchenne and other X-linked muscular dystrophies. In: Rimoin D, Connor JM, Pieritz RE, editors. Principle and practice of medical genetics. Edinburgh: Churchill Livingstone, 1996: 2337–54

Den Dunnen JT, Grootsholten PM, Bakker E, et al. Topography of the DMD gene: FIGE and cDNA analysis of cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989; 45: 835–47

Roberts RG. Dystrophin, its gene, and the dystrophinopathies. Adv Genet 1995; 33: 177–231

Nobile C, Galvagni F, Marchi J, et al. Genomic organization of the human dystrophin gene across the major deletion hot spot and 3′ region. Genomics 1995; 28: 97–100

Tennyson CN, Klamut HJ, Worton RG. The human dystrophin gene requires 16 hours to transcribe and is cotranscriptionally spliced. Nat Genet 1995; 9: 184–90

Ahn AH, Kunkel LM. The structure and functional diversity of dystrophin. Nat Genet 1993; 3: 283–91

Lidov HG, Selig S, Kunkel LM. Dpl40: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 1995; 4: 329–35

Zubrzycka-Gaam EF, Bulman DE, Karpati G, et al. The Duchenne muscular dystrophy gene product is located in sarcolemma of human skeletal muscle. Nature 1988; 333: 466–9

Koenig M, Beggs AH, Moyer M, et al. The molecular bases of Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 1989; 45: 498–506

Center for Human and Clinical Genetics, Leiden University Medical Center. Leiden muscular dystrophy [online]. Available from URL: http://www.dmd.nl [Accessed 2005 Jun 17]

Hoffman EP, Dressman D. Molecular pathophisiology and targeted therapeutics for muscular dystrophy. Trends Pharmacol Sci 2001; 22: 465–70

Edwards JH. The population genetics of Duchenne: natural and artificial selection in DMD. J Med Genet 1986; 23: 521–30

Barbujani G, Russo A, Danielli GA, et al. Segregation analysis of 1885 families: significant departure from the expected proportion of sporadic cases. Hum Genet 1990; 84: 522–6

Prior TW, Friedman KJ, Highsmith WE, et al. Molecular probe protocol for determining carrier status in Duchenne and Becker muscular dystrophies. Clin Chem 1990; 36: 441–5

Abbs S, Bobrow M. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet 1992; 29: 191–6

Yau SC, Bobrow M, Mathew CC, et al. Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophies by fluorescent dosage analysis. J Med Genet 1996; 33: 550–8

Baranzini SE, Giliberto F, Herrera M, et al. Deletion patterns in Argentine patients with Duchenne and Becker muscular dystrophy. Neurol Res 1998; 20: 409–14

Giliberto F, Ferreiro V, Dalamon V, et al. Dystrophin deletions and cognitive impairment in Duchenne/Becker muscular dystrophy. Neurol Res 2004; 26: 83–7

Hiraishi Y, Kato S, Ishibara T, et al. Quantitative Southern blot analysis in the dystrophin gene of Japanese patients with Duchenne or Becker muscular dystrophy: a high frequency of duplications. J Med Genet 1992; 29: 897–901

Lenk U, Hanke R, Thiele H, et al. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum Mol Genet 1993; 2: 1877–81

Bennett RR, Den Dunnen J, O’Brien KF, et al. Detection of mutations in the dystrophin gene via automated DHPLC screening and sequencing. BMC Genet 2001; 2: 17

Baranzini SE, Lenk U, Szijan I, et al. Four new polymorphisms in the human dystrophin gene from an Argentinian population. Muscle Nerve 1997; 21: 1451–3

Roberts RG, Barby TEM, Manners E, et al. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991; 49: 298–310

Clemens PR, Fenwick RG, Chamberlain JS, et al. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet 1991; 49: 951–60

Feener CA, Boyce FM, Kunkel LM. Rapid detection of CA polymorphisms in cloned DNA: application to the 5′ region of the dystrophin gene. Am J Hum Genet 1991; 48: 621–7

King SC, Stapleton PM, Walker AP, et al. Two dinucleotide repeat polymorphisms at the DMD locus. Hum Mol Genet 1994; 3: 523

Oudet C, Heilig R, Mandel JL. An informative polymorphism detectable by polymerase chain reaction at the 3′ end of the dystrophin gene. Hum Genet 1990; 84: 283–5

Beggs AH, Kunkel LM. A polymorphic CACA repeat in the 3′ untransleted region of dystrophin. Nucleic Acid Res 1990; 18: 1931

Murray MG, Thompson WE. Rapid isolation of high molecular-weight plant DNA. Nucleic Acids Res 1980; 8: 4321–5

Köchling S, den Dunnen JT, Dwornnniczak B, et al. Two polymorphic dinucleotide repeats in intron 44 of the dystrophin gene. Hum Genet 1995; 95: 475–7

Baranzini SE, Giliberto F, Dalamon V, et al. Carrier detection in Duchenne and Becker muscular dystrophy Argentine families. Clin Genet 1998; 54: 503–11

Ferreiro V, Szijan I, Giliberto F. Detection of germline mosaicism in two Duchenne muscular dystrophy families using polymorphic dinucleotide (CA)n repeat loci within the dystrophin gene. Mol Diagn 2004; 8(2): 115–21

Essen AJ, Mulder IM, van der Vlies P, et al. Detection of point mutation in dystrophin gene reveals somatic and germline mosaicism in the mother of a patient with Duchenne muscular dystrophy. Am J Med Genet 2003; 118A: 296–8

Chaturvedi LS, Mittal RD, Srivastava S, et al. Analysis of dinucleotide repeat loci of dystrophin gene for carrier detection, germline mosaicism and de novo mutations in Duchenne muscular dystrophy. Clin Genet 2000; 58(3): 234–6

Castiglia VC. In: Principios de investigatión biomédica. 2nd ed. Buenos Aires: Estudio de Proyectos Cientificos, 1998

Giliberto F, Ferreiro V, Dalamon V, et al. Direct deletion analysis in two Duchenne muscular dystrophy symptomatic females using polymorphic dinucleotide (CA)n loci within the dystrophin gene. J Biochem and Molec Biol 2003; 36: 179–84

Minetti C, Ghang HW, Medori R, et al. Dystrophin deficiency in young girls with sporadic myopathy and normal kariotype. Neurology 1991; 41: 1288–92

Nonaka I, Sugita H, Arahata K. The frequency of patients with dystrophin abnormalities in a limb-girdle patient’s population. Neurology 1991; 41: 1491–6

Pegoraro E, Neil SR, Hoffman EP. Detection of known paternal Dystrophin gene mutation in isolated cases of dystrophinopathy in females. Am J Hum Genet 1994; 54: 989–1003

Llense S, Peccate C, Barbot JC, et al. A single step fast screening method to scan the DMD gene for any defect altering the number of nucleotides in patients and in female carriers. Neuromuscl Disord 2003, 13: 625

Kayser M, Roewer L, Hedman M, et al. Characteristic and frequency of germline mutations at microsatellite loci from the human Y chromosome, as revealed by direct observation in father/son pairs. Am J Hum Genet 2000; 66: 1580–8

Brinkmann B, Klintschar M, Neuhuber F, et al. Mutation rate in human microsatellites: influence of the structure and length of tandem repeat. Am J Hum Genet 1998; 62: 1408–15

Schlötterer C, Tautz D. Slippage synthesis of simple sequence DNA. Nucleic Acids Res 1992; 20: 211–5

Saha A, Bairva NK, Bamezai R. Microsatellite instability: an indirect assay to detect defects in the cellular mismatch repair machinery. Methods Mol Biol 2004; 291: 293–302

Yamada NA, Smith GA, Castro A, et al. Relative rates of insertion and deletion mutations in dinucleotide repeats of various lengths in mismatch repair proficient mouse and mismatch repair deficient human cells. Mutat Res 2002; 499: 213–25